Episode Details
Back to EpisodesEp. 109: The Impact of Aging on MS: Comorbidities, Polypharmacy and Disease Modifying Treatments
Published 1 year, 6 months ago
Description
Moderator: Melinda Magyari (Copenhagen, Denmark)
Guest: Thomas Berger (Vienna, Austria)
Melinda Magyari and her guest Thomas Berger talk about how aging affects MS progression and management, focusing on immunosenescence's impact on the immune response
Moderator: Melinda Magyari (Copenhagen, Denmark)
Guest: Thomas Berger (Vienna, Austria)
Melinda Magyari and her guest Thomas Berger talk about how aging affects MS progression and management, focusing on immunosenescence's impact on the immune response and DMT effectiveness. They cover the rise of comorbidities in older MS patients, the challenges of using DMTs over age 55, the lack of clinical trials for this age group, and share lifestyle tips to improve quality of life and health outcomes.